Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax

Russia has granted approval for clinical trials to be held for the Chinese COVID-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.

Ad5-nCoV is a vaccine candidate co-developed by CanSino Biologics and a Chinese military-backed research unit.

(Writing by Tom Balmforth; editing by Louise Heavens)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.